Early-Onset Noncommunicable Disease and Multimorbidity Among Adults With Pediatric-Onset Disabilities.
Sign Up to like & getrecommendations! Published in 2019 at "Mayo Clinic proceedings"
DOI: 10.1016/j.mayocp.2019.07.010
Abstract: OBJECTIVE To determine the prevalence of major noncommunicable diseases among young adults with pediatric-onset disabilities (PoDs) compared with young adults without PoDs. PATIENTS AND METHODS Data were obtained from the Optum Clinformatics Data Mart, a… read more here.
Keywords: disease; multimorbidity; noncommunicable diseases; pediatric onset ... See more keywords
Outcomes on Social and Classic Cognition in adults with Pediatric-onset Multiple Sclerosis.
Sign Up to like & getrecommendations! Published in 2021 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2021.103071
Abstract: BACKGROUND Cognitive impairment affecting classic and social domains has been consistently reported in patients with Multiple Sclerosis (MS). However, little is known about the cognitive outcomes, particularly on social cognition, in adults with pediatric-onset multiple… read more here.
Keywords: sclerosis; age; multiple sclerosis; cognition adults ... See more keywords
Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update
Sign Up to like & getrecommendations! Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11020173
Abstract: The current antimicrobial therapy of bacterial infections of the central nervous system (CNS) in adults and pediatric patients is faced with many pitfalls as the drugs have to reach necessary levels in serum and cross… read more here.
Keywords: vancomycin meropenem; central nervous; adults pediatric; pediatric patients ... See more keywords